Quick Takeaways: Why It Matters? If the science holds up, this could open a future premium category for hypoallergenic dogs and related breeding or licensing programs, creating new value in the pet biotech space while also raising major regulatory, ethical, and animal-welfare h...
Quick Takeaways Why It Matters? Zoetis vaults into genomics leadership, fusing Neogen’s lab network with its biologics portfolio to dominate precision breeding and herd management. Deal crushes smaller agtech players, handing ranchers data-driven productiv...
